Amundi Pacira Bio Sciences, Inc. Transaction History

Amundi

$253 Billion
Q2 2024

A detailed history of Amundi transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Amundi holds 6,972 shares of PCRX stock, worth $101,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,972

Holding current value

$101,372

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $177,786 - $219,687	6,972 New	6,972 $199,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $155,939 - $184,423	2,635 New	2,635 $160,000

Others Institutions Holding PCRX

# of Institutions

301

Shares Held

51.5M

Call Options Held

378K

Put Options Held

1.53M

Black Rock Inc. New York, NY

8.01M
Shares

$116 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.08M
Shares

$73.9 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.16M
Shares

$31.4 Million
0.16% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.07M
Shares

$30 Million
0.1% of portfolio
State Street Corp Boston, MA

1.9M
Shares

$27.7 Million
0.0% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $666M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account